| Style | Citing Format |
|---|---|
| MLA | Souri Z, Malekahmadi M. "Redox, Inflammatory, and Ferroptosis Pathway Modulation by Methotrexate and Dexamethasone in Primary Human Rpe Cells Under Basal and Acute H₂o₂-Induced Oxidative Stress: An in Vitro Study." Biomedicine and Pharmacotherapy, vol. 196, no. , 2026, pp. -. |
| APA | Souri Z, Malekahmadi M (2026). Redox, Inflammatory, and Ferroptosis Pathway Modulation by Methotrexate and Dexamethasone in Primary Human Rpe Cells Under Basal and Acute H₂o₂-Induced Oxidative Stress: An in Vitro Study. Biomedicine and Pharmacotherapy, 196(), -. |
| Chicago | Souri Z, Malekahmadi M. "Redox, Inflammatory, and Ferroptosis Pathway Modulation by Methotrexate and Dexamethasone in Primary Human Rpe Cells Under Basal and Acute H₂o₂-Induced Oxidative Stress: An in Vitro Study." Biomedicine and Pharmacotherapy 196, no. (2026): -. |
| Harvard | Souri Z, Malekahmadi M (2026) 'Redox, Inflammatory, and Ferroptosis Pathway Modulation by Methotrexate and Dexamethasone in Primary Human Rpe Cells Under Basal and Acute H₂o₂-Induced Oxidative Stress: An in Vitro Study', Biomedicine and Pharmacotherapy, 196(), pp. -. |
| Vancouver | Souri Z, Malekahmadi M. Redox, Inflammatory, and Ferroptosis Pathway Modulation by Methotrexate and Dexamethasone in Primary Human Rpe Cells Under Basal and Acute H₂o₂-Induced Oxidative Stress: An in Vitro Study. Biomedicine and Pharmacotherapy. 2026;196():-. |
| BibTex | @article{ author = {Souri Z and Malekahmadi M}, title = {Redox, Inflammatory, and Ferroptosis Pathway Modulation by Methotrexate and Dexamethasone in Primary Human Rpe Cells Under Basal and Acute H₂o₂-Induced Oxidative Stress: An in Vitro Study}, journal = {Biomedicine and Pharmacotherapy}, volume = {196}, number = {}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Souri Z AU - Malekahmadi M TI - Redox, Inflammatory, and Ferroptosis Pathway Modulation by Methotrexate and Dexamethasone in Primary Human Rpe Cells Under Basal and Acute H₂o₂-Induced Oxidative Stress: An in Vitro Study JO - Biomedicine and Pharmacotherapy VL - 196 IS - SP - EP - PY - 2026 ER - |